The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global (-)-Blebbistatin Market Research Report 2025
Synopsis
(-)-Blebbistatin (CAS 856925-71-8) is a yellow solid, a cell-permeable non-muscle myosin II ATPase inhibitor, which can be inactivated by blue light.
Global (-)-Blebbistatin market is projected to reach US$ 14 million in 2029, increasing from US$ 10 million in 2022, with the CAGR of 3.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole (-)-Blebbistatin market research.
(-)-Blebbistatin is a commonly used compound in biochemical research, primarily employed to inhibit the activity of myosin II, thus blocking muscle contraction. Currently, in the field of biomedicine, there is a gradual increase in the demand for (-)-Blebbistatin, particularly as its applications continue to expand in cell biology and biomedical research. The market size is relatively small, mainly constrained by its high cost and specialized use. However, with the advancement of biomedical technology and a deeper understanding of cellular functions, it is expected that the market for (-)-Blebbistatin will expand in the future and has the potential to become an essential tool for broader applications.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global (-)-Blebbistatin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Adooq Bioscience
BioCrick
ChemScence
Key Organics
AK Scientific
APExBIO Technology
Bio-Techne
Glentham Life Sciences
CSNpharm
DC Chemicals
Merck
BOC Sciences
Segment by Type
Purity 97%
Purity 98%
Purity 99%
Others
Segment by Application
Industries
Laboratories
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The (-)-Blebbistatin report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
(-)-Blebbistatin (CAS 856925-71-8) is a yellow solid, a cell-permeable non-muscle myosin II ATPase inhibitor, which can be inactivated by blue light.
Global (-)-Blebbistatin market is projected to reach US$ 14 million in 2029, increasing from US$ 10 million in 2022, with the CAGR of 3.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole (-)-Blebbistatin market research.
(-)-Blebbistatin is a commonly used compound in biochemical research, primarily employed to inhibit the activity of myosin II, thus blocking muscle contraction. Currently, in the field of biomedicine, there is a gradual increase in the demand for (-)-Blebbistatin, particularly as its applications continue to expand in cell biology and biomedical research. The market size is relatively small, mainly constrained by its high cost and specialized use. However, with the advancement of biomedical technology and a deeper understanding of cellular functions, it is expected that the market for (-)-Blebbistatin will expand in the future and has the potential to become an essential tool for broader applications.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global (-)-Blebbistatin market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Adooq Bioscience
BioCrick
ChemScence
Key Organics
AK Scientific
APExBIO Technology
Bio-Techne
Glentham Life Sciences
CSNpharm
DC Chemicals
Merck
BOC Sciences
Segment by Type
Purity 97%
Purity 98%
Purity 99%
Others
Segment by Application
Industries
Laboratories
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The (-)-Blebbistatin report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Index1 (-)-Blebbistatin Market Overview
1.1 Product Definition
1.2 (-)-Blebbistatin Segment by Type
1.2.1 Global (-)-Blebbistatin Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Purity 97%
1.2.3 Purity 98%
1.2.4 Purity 99%
1.2.5 Others
1.3 (-)-Blebbistatin Segment by Application
1.3.1 Global (-)-Blebbistatin Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Industries
1.3.3 Laboratories
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global (-)-Blebbistatin Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global (-)-Blebbistatin Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global (-)-Blebbistatin Production Estimates and Forecasts (2018-2029)
1.4.4 Global (-)-Blebbistatin Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global (-)-Blebbistatin Production Market Share by Manufacturers (2018-2023)
2.2 Global (-)-Blebbistatin Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of (-)-Blebbistatin, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global (-)-Blebbistatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global (-)-Blebbistatin Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of (-)-Blebbistatin, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of (-)-Blebbistatin, Product Offered and Application
2.8 Global Key Manufacturers of (-)-Blebbistatin, Date of Enter into This Industry
2.9 (-)-Blebbistatin Market Competitive Situation and Trends
2.9.1 (-)-Blebbistatin Market Concentration Rate
2.9.2 Global 5 and 10 Largest (-)-Blebbistatin Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 (-)-Blebbistatin Production by Region
3.1 Global (-)-Blebbistatin Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global (-)-Blebbistatin Production Value by Region (2018-2029)
3.2.1 Global (-)-Blebbistatin Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of (-)-Blebbistatin by Region (2024-2029)
3.3 Global (-)-Blebbistatin Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global (-)-Blebbistatin Production by Region (2018-2029)
3.4.1 Global (-)-Blebbistatin Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of (-)-Blebbistatin by Region (2024-2029)
3.5 Global (-)-Blebbistatin Market Price Analysis by Region (2018-2023)
3.6 Global (-)-Blebbistatin Production and Value, Year-over-Year Growth
3.6.1 North America (-)-Blebbistatin Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe (-)-Blebbistatin Production Value Estimates and Forecasts (2018-2029)
3.6.3 China (-)-Blebbistatin Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan (-)-Blebbistatin Production Value Estimates and Forecasts (2018-2029)
4 (-)-Blebbistatin Consumption by Region
4.1 Global (-)-Blebbistatin Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global (-)-Blebbistatin Consumption by Region (2018-2029)
4.2.1 Global (-)-Blebbistatin Consumption by Region (2018-2023)
4.2.2 Global (-)-Blebbistatin Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America (-)-Blebbistatin Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America (-)-Blebbistatin Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe (-)-Blebbistatin Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe (-)-Blebbistatin Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific (-)-Blebbistatin Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific (-)-Blebbistatin Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa (-)-Blebbistatin Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa (-)-Blebbistatin Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global (-)-Blebbistatin Production by Type (2018-2029)
5.1.1 Global (-)-Blebbistatin Production by Type (2018-2023)
5.1.2 Global (-)-Blebbistatin Production by Type (2024-2029)
5.1.3 Global (-)-Blebbistatin Production Market Share by Type (2018-2029)
5.2 Global (-)-Blebbistatin Production Value by Type (2018-2029)
5.2.1 Global (-)-Blebbistatin Production Value by Type (2018-2023)
5.2.2 Global (-)-Blebbistatin Production Value by Type (2024-2029)
5.2.3 Global (-)-Blebbistatin Production Value Market Share by Type (2018-2029)
5.3 Global (-)-Blebbistatin Price by Type (2018-2029)
6 Segment by Application
6.1 Global (-)-Blebbistatin Production by Application (2018-2029)
6.1.1 Global (-)-Blebbistatin Production by Application (2018-2023)
6.1.2 Global (-)-Blebbistatin Production by Application (2024-2029)
6.1.3 Global (-)-Blebbistatin Production Market Share by Application (2018-2029)
6.2 Global (-)-Blebbistatin Production Value by Application (2018-2029)
6.2.1 Global (-)-Blebbistatin Production Value by Application (2018-2023)
6.2.2 Global (-)-Blebbistatin Production Value by Application (2024-2029)
6.2.3 Global (-)-Blebbistatin Production Value Market Share by Application (2018-2029)
6.3 Global (-)-Blebbistatin Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Adooq Bioscience
7.1.1 Adooq Bioscience (-)-Blebbistatin Corporation Information
7.1.2 Adooq Bioscience (-)-Blebbistatin Product Portfolio
7.1.3 Adooq Bioscience (-)-Blebbistatin Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Adooq Bioscience Main Business and Markets Served
7.1.5 Adooq Bioscience Recent Developments/Updates
7.2 BioCrick
7.2.1 BioCrick (-)-Blebbistatin Corporation Information
7.2.2 BioCrick (-)-Blebbistatin Product Portfolio
7.2.3 BioCrick (-)-Blebbistatin Production, Value, Price and Gross Margin (2018-2023)
7.2.4 BioCrick Main Business and Markets Served
7.2.5 BioCrick Recent Developments/Updates
7.3 ChemScence
7.3.1 ChemScence (-)-Blebbistatin Corporation Information
7.3.2 ChemScence (-)-Blebbistatin Product Portfolio
7.3.3 ChemScence (-)-Blebbistatin Production, Value, Price and Gross Margin (2018-2023)
7.3.4 ChemScence Main Business and Markets Served
7.3.5 ChemScence Recent Developments/Updates
7.4 Key Organics
7.4.1 Key Organics (-)-Blebbistatin Corporation Information
7.4.2 Key Organics (-)-Blebbistatin Product Portfolio
7.4.3 Key Organics (-)-Blebbistatin Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Key Organics Main Business and Markets Served
7.4.5 Key Organics Recent Developments/Updates
7.5 AK Scientific
7.5.1 AK Scientific (-)-Blebbistatin Corporation Information
7.5.2 AK Scientific (-)-Blebbistatin Product Portfolio
7.5.3 AK Scientific (-)-Blebbistatin Production, Value, Price and Gross Margin (2018-2023)
7.5.4 AK Scientific Main Business and Markets Served
7.5.5 AK Scientific Recent Developments/Updates
7.6 APExBIO Technology
7.6.1 APExBIO Technology (-)-Blebbistatin Corporation Information
7.6.2 APExBIO Technology (-)-Blebbistatin Product Portfolio
7.6.3 APExBIO Technology (-)-Blebbistatin Production, Value, Price and Gross Margin (2018-2023)
7.6.4 APExBIO Technology Main Business and Markets Served
7.6.5 APExBIO Technology Recent Developments/Updates
7.7 Bio-Techne
7.7.1 Bio-Techne (-)-Blebbistatin Corporation Information
7.7.2 Bio-Techne (-)-Blebbistatin Product Portfolio
7.7.3 Bio-Techne (-)-Blebbistatin Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Bio-Techne Main Business and Markets Served
7.7.5 Bio-Techne Recent Developments/Updates
7.8 Glentham Life Sciences
7.8.1 Glentham Life Sciences (-)-Blebbistatin Corporation Information
7.8.2 Glentham Life Sciences (-)-Blebbistatin Product Portfolio
7.8.3 Glentham Life Sciences (-)-Blebbistatin Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Glentham Life Sciences Main Business and Markets Served
7.7.5 Glentham Life Sciences Recent Developments/Updates
7.9 CSNpharm
7.9.1 CSNpharm (-)-Blebbistatin Corporation Information
7.9.2 CSNpharm (-)-Blebbistatin Product Portfolio
7.9.3 CSNpharm (-)-Blebbistatin Production, Value, Price and Gross Margin (2018-2023)
7.9.4 CSNpharm Main Business and Markets Served
7.9.5 CSNpharm Recent Developments/Updates
7.10 DC Chemicals
7.10.1 DC Chemicals (-)-Blebbistatin Corporation Information
7.10.2 DC Chemicals (-)-Blebbistatin Product Portfolio
7.10.3 DC Chemicals (-)-Blebbistatin Production, Value, Price and Gross Margin (2018-2023)
7.10.4 DC Chemicals Main Business and Markets Served
7.10.5 DC Chemicals Recent Developments/Updates
7.11 Merck
7.11.1 Merck (-)-Blebbistatin Corporation Information
7.11.2 Merck (-)-Blebbistatin Product Portfolio
7.11.3 Merck (-)-Blebbistatin Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Merck Main Business and Markets Served
7.11.5 Merck Recent Developments/Updates
7.12 BOC Sciences
7.12.1 BOC Sciences (-)-Blebbistatin Corporation Information
7.12.2 BOC Sciences (-)-Blebbistatin Product Portfolio
7.12.3 BOC Sciences (-)-Blebbistatin Production, Value, Price and Gross Margin (2018-2023)
7.12.4 BOC Sciences Main Business and Markets Served
7.12.5 BOC Sciences Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 (-)-Blebbistatin Industry Chain Analysis
8.2 (-)-Blebbistatin Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 (-)-Blebbistatin Production Mode & Process
8.4 (-)-Blebbistatin Sales and Marketing
8.4.1 (-)-Blebbistatin Sales Channels
8.4.2 (-)-Blebbistatin Distributors
8.5 (-)-Blebbistatin Customers
9 (-)-Blebbistatin Market Dynamics
9.1 (-)-Blebbistatin Industry Trends
9.2 (-)-Blebbistatin Market Drivers
9.3 (-)-Blebbistatin Market Challenges
9.4 (-)-Blebbistatin Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
